TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea
· Delayed Price · Currency is KRW 636.00
-3.00 (-0.47%)
Apr 29, 2026, 3:30 PM KST
TELCON RF PHARMACEUTICAL. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -11,456 | -26,320 | 13,906 | -42,084 | -23,098 | Upgrade
|
| Depreciation & Amortization | 4,824 | 4,507 | 4,244 | 4,281 | 4,200 | Upgrade
|
| Loss (Gain) From Sale of Assets | -486.92 | -17.27 | 14.8 | -34.38 | 250.45 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1,324 | 1,097 | 64.8 | 4,411 | 3,005 | Upgrade
|
| Loss (Gain) From Sale of Investments | 5,817 | -1,275 | -13,466 | 13,146 | -4,626 | Upgrade
|
| Loss (Gain) on Equity Investments | 3,709 | 24,684 | -469.53 | 17,868 | 13,196 | Upgrade
|
| Provision & Write-off of Bad Debts | -417.28 | 206.34 | 251.8 | 746.56 | -19.19 | Upgrade
|
| Other Operating Activities | 1,041 | 618.75 | 963.05 | 2,648 | 7,383 | Upgrade
|
| Change in Accounts Receivable | -2,958 | -3,908 | -6,563 | -1,450 | -791.38 | Upgrade
|
| Change in Inventory | -1,119 | 528.74 | -717.74 | -1,684 | -677.17 | Upgrade
|
| Change in Accounts Payable | 1,145 | 1,572 | 503.37 | 646.52 | 60.21 | Upgrade
|
| Change in Other Net Operating Assets | 242.36 | -474.55 | 133.25 | -586.66 | 758.06 | Upgrade
|
| Operating Cash Flow | 1,667 | 1,219 | -1,135 | -2,093 | -358.56 | Upgrade
|
| Operating Cash Flow Growth | 36.73% | - | - | - | - | Upgrade
|
| Capital Expenditures | -319.81 | -4,968 | -3,820 | -819.43 | -2,254 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 18.05 | 5.88 | 66.81 | 60.24 | Upgrade
|
| Cash Acquisitions | -30.98 | - | - | - | - | Upgrade
|
| Divestitures | 505.56 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -7.13 | -18 | -14.52 | -3,559 | Upgrade
|
| Investment in Securities | 6,401 | -44,536 | 419.38 | -7,082 | 6,508 | Upgrade
|
| Other Investing Activities | 194.38 | 38.83 | -32.32 | 46.34 | 124.26 | Upgrade
|
| Investing Cash Flow | -1,345 | -44,084 | -10,525 | -7,885 | 879.02 | Upgrade
|
| Short-Term Debt Issued | 2,800 | 36,600 | - | 200 | - | Upgrade
|
| Long-Term Debt Issued | 11,880 | 29,780 | 13,108 | 1,000 | - | Upgrade
|
| Total Debt Issued | 14,680 | 66,380 | 13,108 | 1,200 | - | Upgrade
|
| Short-Term Debt Repaid | -19,400 | -18,000 | -200 | - | - | Upgrade
|
| Long-Term Debt Repaid | -12,715 | -10,737 | -2,947 | -4,640 | -1,922 | Upgrade
|
| Total Debt Repaid | -32,115 | -28,737 | -3,147 | -4,640 | -1,922 | Upgrade
|
| Net Debt Issued (Repaid) | -17,435 | 37,643 | 9,961 | -3,440 | -1,922 | Upgrade
|
| Issuance of Common Stock | 40,193 | - | - | - | - | Upgrade
|
| Other Financing Activities | -252.59 | 8.55 | 484.74 | - | 31.01 | Upgrade
|
| Financing Cash Flow | 22,505 | 37,651 | 10,445 | -3,440 | -1,891 | Upgrade
|
| Foreign Exchange Rate Adjustments | -7.65 | 0.6 | -0.46 | -43.32 | 24.42 | Upgrade
|
| Net Cash Flow | 22,819 | -5,213 | -1,214 | -13,462 | -1,346 | Upgrade
|
| Free Cash Flow | 1,347 | -3,749 | -4,954 | -2,912 | -2,613 | Upgrade
|
| Free Cash Flow Margin | 3.12% | -9.90% | -13.64% | -10.46% | -6.90% | Upgrade
|
| Free Cash Flow Per Share | 28.10 | -105.69 | -110.43 | -70.69 | -99.13 | Upgrade
|
| Cash Interest Paid | 2,065 | 1,304 | 553.73 | 861.4 | 2,419 | Upgrade
|
| Cash Income Tax Paid | -213.9 | 200.01 | 45.14 | -27.4 | 40.1 | Upgrade
|
| Levered Free Cash Flow | -8,886 | 10,349 | -5,322 | 316 | -7,715 | Upgrade
|
| Unlevered Free Cash Flow | -5,878 | 12,699 | -4,945 | 980.21 | -2,901 | Upgrade
|
| Change in Working Capital | -2,689 | -2,282 | -6,644 | -3,074 | -650.28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.